Search Results

Neural Therapeutics Inc. (“Neural” or the “Company”), an ethnobotanical drug discovery company dedicated to developing therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioids, wishes to announce that Dr. Kelly Narine and Professor Jason Dyck have resigned as directors of Neural, and Dr. Carlos Davidovich was appointed as a new director.

Toronto, Ontario--(Newsfile Corp. - May 8, 2024) - Neural Therapeutics Inc. (“Neural” or the “Company”), an ethnobotanical drug discovery company dedicated to developing therapeutic drugs for mental ailments related to substance use disorders...

CIONIC, the neurotech inventor pioneering bionic clothing, today announced data showcasing the impact of the FDA-cleared Cionic Neural Sleeve as assistive technology for individuals experiencing difficulty walking due to multiple sclerosis (MS).

CIONIC announced three new additions to its national Centers of Excellence program, which provides leading neurological medical centers with exclusive training and access to utilize the Cionic Neural Sleeve in the clinical care of patients with mobility impairments.

Neural Therapeutics Inc. (“Neural” or the “Company”) is pleased to announce the formal appointment of Dr. Jason Dyck, Dr. Kelly Narine and Colin McLelland to the Company’s board of directors.